U.S. Physical Therapy (NYSE:USPH – Get Free Report) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued on Wednesday,Zacks.com reports.
USPH has been the subject of several other reports. Jefferies Financial Group upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Thursday, March 12th. Barrington Research decreased their price objective on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a report on Wednesday, May 13th. Citizens Jmp decreased their price objective on shares of U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating for the company in a report on Friday, May 8th. Finally, Citigroup restated an “outperform” rating on shares of U.S. Physical Therapy in a report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $97.50.
View Our Latest Stock Analysis on USPH
U.S. Physical Therapy Stock Performance
U.S. Physical Therapy (NYSE:USPH – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.46 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.09). U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The company had revenue of $198.29 million for the quarter, compared to analysts’ expectations of $200.94 million. During the same period in the previous year, the firm posted $0.48 earnings per share. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. As a group, research analysts expect that U.S. Physical Therapy will post 2.99 earnings per share for the current year.
Insider Activity at U.S. Physical Therapy
In related news, COO Graham D. Reeve sold 662 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $78.86, for a total transaction of $52,205.32. Following the sale, the chief operating officer directly owned 30,078 shares in the company, valued at $2,371,951.08. The trade was a 2.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Richard Binstein sold 3,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Friday, March 6th. The shares were sold at an average price of $81.64, for a total value of $244,920.00. Following the sale, the executive vice president owned 24,867 shares in the company, valued at $2,030,141.88. This represents a 10.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 2.40% of the company’s stock.
Institutional Investors Weigh In On U.S. Physical Therapy
Several hedge funds have recently made changes to their positions in the company. Bank of America Corp DE boosted its position in shares of U.S. Physical Therapy by 10.9% during the first quarter. Bank of America Corp DE now owns 554,621 shares of the company’s stock valued at $41,574,000 after purchasing an additional 54,656 shares in the last quarter. California State Teachers Retirement System boosted its holdings in U.S. Physical Therapy by 41.4% in the first quarter. California State Teachers Retirement System now owns 19,687 shares of the company’s stock worth $1,476,000 after acquiring an additional 5,763 shares in the last quarter. Royal Bank of Canada boosted its holdings in U.S. Physical Therapy by 22.0% in the first quarter. Royal Bank of Canada now owns 133,777 shares of the company’s stock worth $10,029,000 after acquiring an additional 24,081 shares in the last quarter. Quantinno Capital Management LP boosted its holdings in U.S. Physical Therapy by 13.3% in the first quarter. Quantinno Capital Management LP now owns 8,648 shares of the company’s stock worth $648,000 after acquiring an additional 1,014 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its holdings in U.S. Physical Therapy by 23.4% in the first quarter. Renaissance Technologies LLC now owns 76,956 shares of the company’s stock worth $5,769,000 after acquiring an additional 14,582 shares in the last quarter.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.
In addition to traditional rehabilitation services, U.S.
See Also
- Five stocks we like better than U.S. Physical Therapy
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.
